Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922920 · ClinicalTrials.gov registry record · NA

Effects of Tart Cherry Juice on the Body

A NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT02922920 is a NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors that has completed, run by University of Delaware. The registered enrollment target is 37 participants, below the 1,130-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922920, a NA study of Age-related Cognitive Decline and Cardiovascular Risk Factors, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

Tart cherries are a rich source of antioxidants. Studies have shown that tart cherries exert anti-oxidative and anti-inflammatory properties. The purpose of this study is to learn about the effects of drinking tart cherry juice on cardiovascular and cognitive health.

Interventions

  • OTHER Placebo
  • OTHER Tart cherry juice

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2014-11
Est. Completion 2016-09
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT02922920

The ClinicalTrials.gov registry entry for NCT02922920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,130-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (97% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02922920 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT02922920 about?

NCT02922920 is a clinical study titled "Effects of Tart Cherry Juice on the Body". Tart cherries are a rich source of antioxidants. Studies have shown that tart cherries exert anti-oxidative and anti-inflammatory properties. The purpose of this study is to learn about the effects of drinking tart cherry juice on cardiovascular and cognitive health.

What is the current status of trial NCT02922920?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2014-11. Estimated completion is 2016-09.

What conditions does trial NCT02922920 study?

This clinical trial studies the following conditions: Age-related Cognitive Decline, Cardiovascular Risk Factors.

What interventions are being tested in trial NCT02922920?

The interventions under investigation include: Placebo (OTHER), Tart cherry juice (OTHER).

Who is sponsoring clinical trial NCT02922920?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02922920 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Age-related Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.